eBooks & Guides

Going small to win big: Fragment-based screening in drug discovery

Issue link: https://resources.nanotempertech.com/i/1133236

Contents of this Issue

Navigation

Page 10 of 20

11 Surface Plasmon Resonance Surface plasmon resonance (SPR) is a highly sensitive and precise method that provides kinetic and affinity information. It's considered a gold standard, and has many established standard protocols. Because of its quantitative aspects, SPR is also used to help determine SARs of fragment analogs during downstream lead optimization. This method involves flowing solubilized analyte across a target protein that has been immobilized to the surface of a sensor chip. Analyte binding increases the mass immobilized on the chip; an event detectable by measuring changes in the refractive index of light shone onto the chip. By testing different analyte concentrations flowed over a constant amount of immobilized target, the k on , k off and K d of the interaction can be determined. Optimization of the capture for each target is required and o en overlooked, which may be the reason for lack of correlation with other orthogonal techniques. For example, hit identification and subsequent lead optimization have different requirements for capture density. During hit identification, one looks for high density of captured protein whereas with lead optimization, one looks for the opposite — less capture of target protein is desired. Sensor chips can be reused by removing the analyte bound to the sensor chip. Not to be overlooked, chip regeneration conditions must be optimized to completely remove bound analyte while conserving the activity of the captured target protein. Ideal for binding kinetics and constants using label- free detection Immobilization of one of the binding partners, interference by DMSO (a common solvent for fragments) and regular maintenance of its fluidics components are known obstacles

Articles in this issue

view archives of eBooks & Guides - Going small to win big: Fragment-based screening in drug discovery